Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8736) 8736
Newspaper Article (381) 381
Book Chapter (178) 178
Newsletter (41) 41
Magazine Article (34) 34
Dissertation (8) 8
Trade Publication Article (8) 8
Transcript (6) 6
Book Review (3) 3
Conference Proceeding (2) 2
Reference (2) 2
Web Resource (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (6476) 6476
life sciences & biomedicine (6206) 6206
humans (5684) 5684
dopamine (4373) 4373
male (3596) 3596
neurosciences & neurology (3200) 3200
female (2771) 2771
animals (2614) 2614
neurosciences (2422) 2422
biological and medical sciences (2203) 2203
medical sciences (2107) 2107
parkinson's disease (1834) 1834
clinical neurology (1800) 1800
pharmacology & pharmacy (1782) 1782
middle aged (1742) 1742
parkinson disease - drug therapy (1668) 1668
psychiatry (1667) 1667
adult (1543) 1543
dopamine agonists - therapeutic use (1516) 1516
neurology (1513) 1513
dopamine agonists - adverse effects (1293) 1293
aged (1280) 1280
pharmacology. drug treatments (1206) 1206
rats (1044) 1044
parkinsons disease (961) 961
dopamine - metabolism (952) 952
treatment outcome (891) 891
drug therapy (863) 863
dose-response relationship, drug (816) 816
schizophrenia (810) 810
antiparkinson agents - adverse effects (777) 777
antiparkinson agents - therapeutic use (712) 712
neuropharmacology (709) 709
dopamine receptors (697) 697
research (697) 697
movement disorders (686) 686
levodopa - adverse effects (684) 684
serotonin (659) 659
care and treatment (638) 638
psychology. psychoanalysis. psychiatry (634) 634
dopamine agonists - administration & dosage (617) 617
medicine & public health (615) 615
drug dosages (607) 607
levodopa - therapeutic use (601) 601
psychopharmacology (599) 599
abridged index medicus (587) 587
nervous system (585) 585
patients (582) 582
analysis (576) 576
clinical trials (554) 554
risk factors (550) 550
double-blind method (540) 540
levodopa (540) 540
studies (534) 534
rats, sprague-dawley (521) 521
neurodegenerative diseases (517) 517
mental disorders (512) 512
disease models, animal (501) 501
rodents (488) 488
health aspects (482) 482
mice (473) 473
dopamine agonists - pharmacology (469) 469
psychotropic drugs (465) 465
antipsychotic agents - adverse effects (463) 463
brain (462) 462
parkinson’s disease (462) 462
time factors (456) 456
dopamine agonists (449) 449
phenols (449) 449
antipsychotic agents - therapeutic use (446) 446
drugs (438) 438
parkinson disease - physiopathology (432) 432
drug therapy, combination (414) 414
degenerative and inherited degenerative diseases of the nervous system. leukodystrophies. prion diseases (411) 411
dopamine agents - therapeutic use (406) 406
medicine (402) 402
parkinson disease - complications (395) 395
pharmacology (395) 395
pharmacology/toxicology (393) 393
review (393) 393
restless legs syndrome (385) 385
general & internal medicine (379) 379
dosage and administration (376) 376
schizophrenia - drug therapy (374) 374
brain - drug effects (370) 370
psychopathology. psychiatry (370) 370
physiological aspects (367) 367
endocrinology & metabolism (366) 366
cocaine (364) 364
adolescent (358) 358
motor activity - drug effects (347) 347
biomedicine (346) 346
internal medicine (344) 344
toxicology (344) 344
dopamine agents - adverse effects (343) 343
dopamine agonist (343) 343
pharmacotherapy (334) 334
brain - metabolism (333) 333
complications and side effects (331) 331
dopa (331) 331
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9170) 9170
German (70) 70
Spanish (58) 58
French (56) 56
Japanese (43) 43
Russian (19) 19
Portuguese (17) 17
Polish (11) 11
Danish (10) 10
Dutch (9) 9
Hungarian (7) 7
Turkish (6) 6
Chinese (5) 5
Czech (3) 3
Italian (3) 3
Korean (3) 3
Swedish (3) 3
Bulgarian (2) 2
Croatian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation
by Schade, René and Andersohn, Frank and Suissa, Samy and Haverkamp, Wilhelm and Garbe, Edeltraut
The New England journal of medicine, ISSN 0028-4793, 01/2007, Volume 356, Issue 1, pp. 29 - 38
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Parkinson Disease - complications | Humans | Middle Aged | Logistic Models | Male | Dopamine Agonists - adverse effects | Parkinson Disease - drug therapy | Ergolines - adverse effects | Pergolide - adverse effects | Serotonin Receptor Agonists - adverse effects | Antiparkinson Agents - adverse effects | Case-Control Studies | Aged, 80 and over | Heart Valve Diseases - chemically induced | Adult | Female | Aged | Heart Valve Diseases - diagnosis | Serotonin 5-HT2 Receptor Agonists | Cohort Studies | Heart valve diseases | Complications and side effects | Agonists | Dosage and administration | Dopamine | Risk factors | Medical research | Drug abuse | Hospitals | Databases | Informed consent | Risk | Patients | Family physicians | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
by Garcia-Ruiz, Pedro J and Martinez Castrillo, Juan Carlos and Alonso-Canovas, Araceli and Herranz Barcenas, Antonio and Vela, Lydia and Sanchez Alonso, Pilar and Mata, Marina and Olmedilla Gonzalez, Nuria and Mahillo Fernandez, Ignacio
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 08/2014, Volume 85, Issue 8, pp. 840 - 845
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Surgery | Science & Technology | Thiophenes - therapeutic use | Age Factors | Thiophenes - adverse effects | Humans | Middle Aged | Dopamine Agonists - therapeutic use | Tetrahydronaphthalenes - therapeutic use | Male | Dopamine Agonists - adverse effects | Parkinson Disease - drug therapy | Administration, Cutaneous | Tetrahydronaphthalenes - adverse effects | Antiparkinson Agents - therapeutic use | Disruptive, Impulse Control, and Conduct Disorders - psychology | Female | Parkinson Disease - complications | Administration, Oral | Parkinson Disease - psychology | Antiparkinson Agents - adverse effects | Disruptive, Impulse Control, and Conduct Disorders - chemically induced | Indoles - adverse effects | Levodopa - adverse effects | Sex Factors | Indoles - therapeutic use | Aged | Benzothiazoles - therapeutic use | Benzothiazoles - adverse effects | Complications and side effects | Care and treatment | Usage | Parkinson's disease | Dopamine | Agonists | Research | Impulsive personality | Risk factors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Clinical Review and Treatment of Select Adverse Effects of Dopamine Receptor Agonists in Parkinsons Disease
by Wood, Lindy D
Drugs & aging, ISSN 1170-229X, 04/2010, Volume 27, Issue 4, pp. 295 - 310
Parkinson's-disease; treatment | Dopamine-receptor-agonists; therapeutic use | Dopamine-receptor-agonists; adverse reactions | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Neurology | Pharmacology. Drug treatments | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Biological and medical sciences | Nervous system as a whole | Medical sciences | Nervous system (semeiology, syndromes) | Complementary Therapies | Dopamine Agonists - adverse effects | Parkinson Disease - drug therapy | Humans | Dopamine Agonists - therapeutic use | Drugs | Care and treatment | Parkinson's disease | Dopamine | Patient outcomes | Compulsive behavior | Adverse and side effects | Nausea | Complications and side effects | Causes of | Drowsiness | Agonists | Dosage and administration | Drug therapy | Dopa | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs
by Moore, Thomas J and Glenmullen, Joseph and Mattison, Donald R
JAMA internal medicine, ISSN 2168-6106, 12/2014, Volume 174, Issue 12, pp. 1930 - 1933
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | United States | Humans | Middle Aged | Male | Dopamine Agonists - adverse effects | Parkinson Disease - drug therapy | Aripiprazole | Restless Legs Syndrome - drug therapy | Quinolones - adverse effects | Compulsive Behavior - chemically induced | Adult | Female | Retrospective Studies | Sexual Behavior - drug effects | United States Food and Drug Administration | Hyperprolactinemia - drug therapy | Gambling - chemically induced | Impulsive Behavior - drug effects | Piperazines - adverse effects | Receptors, Dopamine D3 - agonists | Drug Labeling | Indoles - adverse effects | Consumer Behavior | Dopamine Agonists - administration & dosage | Aged | Benzothiazoles - adverse effects
Journal Article
Details down arrow
5. Full Text The ABC's of dopamine receptor partial agonists – aripiprazole, brexpiprazole and cariprazine: the 15‐min challenge to sort these agents out
by Citrome, L
International journal of clinical practice (Esher), ISSN 1368-5031, 11/2015, Volume 69, Issue 11, pp. 1211 - 1220
Medicine, General & Internal | Pharmacology & Pharmacy | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Thiophenes - therapeutic use | Drug Administration Schedule | Thiophenes - adverse effects | Antipsychotic Agents - adverse effects | Humans | Dopamine Agonists - therapeutic use | Dopamine Agonists - adverse effects | Piperazines - therapeutic use | Bipolar Disorder - drug therapy | Piperazines - adverse effects | Aripiprazole - adverse effects | Drug Interactions | Quinolones - adverse effects | Antipsychotic Agents - therapeutic use | Quinolones - therapeutic use | Aripiprazole - therapeutic use | Schizophrenia - drug therapy | Depressive Disorder, Major - drug therapy | Aripiprazole | Dopamine | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Stress Cardiomyopathy After Intravenous Administration of Catecholamines and Beta-Receptor Agonists
by Abraham, Jacob and Mudd, James O and Kapur, Navin and Klein, Kelly and Champion, Hunter C and Wittstein, Ilan S
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2009, Volume 53, Issue 15, pp. 1320 - 1325
catecholamines | stress cardiomyopathy | beta-receptor agonists | ventricular ballooning | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiovascular Agents - administration & dosage | Catecholamines - administration & dosage | Humans | Middle Aged | Epinephrine - administration & dosage | Male | Ventricular Dysfunction, Left - chemically induced | Dobutamine - administration & dosage | Epinephrine - adverse effects | Catecholamines - adverse effects | Adrenergic beta-Agonists - administration & dosage | Adult | Female | Infusions, Intravenous | Cardiovascular Agents - adverse effects | Adrenergic beta-Agonists - adverse effects | Dobutamine - adverse effects | Cardiomyopathies - chemically induced | Heart | Heart attacks | Medical imaging | Dopamine | Cardiomyopathy | Cardiovascular disease | Patients | Heart rate | Signal transduction | Pain | Coronary vessels | Suicides & suicide attempts | Electrocardiography | Intubation | Cardiology | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Tolerability and Safety of Ropinirole versus Other Dopamine Agonists and Levodopa in the Treatment of Parkinsons Disease: Meta-Analysis of Randomized Controlled Trials
by Kulisevsky, Jaime and Pagonabarraga, Javier
Drug safety, ISSN 0114-5916, 2010, Volume 33, Issue 2, pp. 147 - 161
Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Toxicology | Life Sciences & Biomedicine | Science & Technology | Antiparkinson Agents - therapeutic use | Indoles - adverse effects | Levodopa - therapeutic use | Humans | Levodopa - adverse effects | Dopamine Agonists - therapeutic use | Indoles - therapeutic use | Dopamine Agonists - adverse effects | Parkinson Disease - drug therapy | Drug Therapy, Combination | Antiparkinson Agents - adverse effects | Randomized Controlled Trials as Topic
Journal Article
Details down arrow
8. Full Text Cardiac and noncardiac fibrotic reactions caused by ergot‐and nonergot‐derived dopamine agonists
by Andersohn, Frank and Garbe, Edeltraut
Movement disorders, ISSN 0885-3185, 01/2009, Volume 24, Issue 1, pp. 129 - 133
adverse drug reaction reporting systems | adverse effects | fibrosis | dopamine agonists | Dopamine agonists | Adverse drug reaction reporting systems | Adverse effects | Fibrosis | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Anticonvulsants. Antiepileptics. Antiparkinson agents | Medical sciences | Neuropharmacology | Pharmacology. Drug treatments | United States - epidemiology | Heart Valve Diseases - pathology | Thiophenes - adverse effects | Humans | Middle Aged | Male | Dopamine Agonists - adverse effects | Bromocriptine - adverse effects | Ergolines - adverse effects | Tetrahydronaphthalenes - adverse effects | Apomorphine - adverse effects | Pulmonary Fibrosis - epidemiology | Pericarditis - epidemiology | Fibrosis - epidemiology | Heart Valve Diseases - epidemiology | Pericarditis - chemically induced | Aged, 80 and over | Heart Valve Diseases - chemically induced | Female | Endomyocardial Fibrosis - chemically induced | Databases, Factual | Fibrosis - chemically induced | Endomyocardial Fibrosis - epidemiology | Pericarditis - pathology | Pleural Diseases - chemically induced | Pergolide - adverse effects | Retroperitoneal Fibrosis - epidemiology | Indoles - adverse effects | Pleural Diseases - epidemiology | Pulmonary Fibrosis - chemically induced | Aged | Retroperitoneal Fibrosis - chemically induced | Benzothiazoles - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease
by Zanettini, Renzo and Antonini, Angelo and Gatto, Gemma and Gentile, Rosa and Tesei, Silvana and Pezzoli, Gianni
The New England journal of medicine, ISSN 0028-4793, 01/2007, Volume 356, Issue 1, pp. 39 - 46
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Endocardial and cardiac valvular diseases | Medical sciences | Parkinson Disease - complications | Parkinson Disease - diagnostic imaging | Humans | Middle Aged | Male | Risk | Dopamine Agonists - adverse effects | Parkinson Disease - drug therapy | Ergolines - adverse effects | Pergolide - adverse effects | Serotonin Receptor Agonists - adverse effects | Case-Control Studies | Regression Analysis | Mitral Valve - diagnostic imaging | Ultrasonography | Heart Valve Diseases - chemically induced | Female | Aged | Mitral Valve - pathology | Serotonin 5-HT2 Receptor Agonists | Heart Valve Diseases - diagnostic imaging | Heart valve diseases | Complications and side effects | Parkinson's disease | Dopamine | Agonists | Dosage and administration | Drug therapy | Risk factors | Drugs | Informed consent | Hospitals | Parkinsons disease | Veins & arteries | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Neurostimulation for Parkinson's Disease with Early Motor Complications
by Schuepbach, W.M.M and Rau, J and Knudsen, K and Volkmann, J and Krack, P and Timmermann, L and Hälbig, T.D and Hesekamp, H and Navarro, S.M and Meier, N and Falk, D and Mehdorn, M and Paschen, S and Maarouf, M and Barbe, M.T and Fink, G.R and Kupsch, A and Gruber, D and Schneider, G.-H and Seigneuret, E and Kistner, A and Chaynes, P and Ory-Magne, F and Brefel Courbon, C and Vesper, J and Schnitzler, A and Wojtecki, L and Houeto, J.-L and Bataille, B and Maltête, D and Damier, P and Raoul, S and Sixel-Doering, F and Hellwig, D and Gharabaghi, A and Krüger, R and Pinsker, M.O and Amtage, F and Régis, J.-M and Witjas, T and Thobois, S and Mertens, P and Kloss, M and Hartmann, A and Oertel, W.H and Post, B and Speelman, H and Agid, Y and Schade-Brittinger, C and Deuschl, G and EARLYSTIM Study Grp and EARLYSTIM Study Group
The New England journal of medicine, ISSN 0028-4793, 02/2013, Volume 368, Issue 7, pp. 610 - 622
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Organic mental disorders. Neuropsychology | General aspects | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Psychopathology. Psychiatry | Biological and medical sciences | Medical sciences | Parkinson Disease - therapy | Subthalamic Nucleus | Humans | Middle Aged | Dopamine Agonists - therapeutic use | Male | Treatment Outcome | Combined Modality Therapy | Dopamine Agonists - adverse effects | Parkinson Disease - drug therapy | Dyskinesias - etiology | Parkinson Disease - physiopathology | Antiparkinson Agents - adverse effects | Activities of Daily Living | Antiparkinson Agents - therapeutic use | Implantable Neurostimulators - adverse effects | Electric Stimulation Therapy - adverse effects | Intention to Treat Analysis | Quality of Life | Adult | Female | Surveys and Questionnaires | Care and treatment | Usage | Parkinson's disease | Patient outcomes | Neurologic examination | Neural stimulation | Diagnosis | Methods | Health care | Basal ganglia | Activities of daily living | Neurodegenerative diseases | Parkinsons disease | Mobility | Central nervous system diseases | Levodopa | Movement disorders | Quality of life | Dyskinesia | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights